Mimedx (MDXG) Cash from Investing Activities (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,584.18% |
| Dec 31, 2025 | 93.63% |
| Sep 30, 2025 | -492.78% |
| Jun 30, 2025 | -118.47% |
| Mar 31, 2025 | 85.33% |
| Dec 31, 2024 | -2,548.67% |
| Sep 30, 2024 | 112.49% |
| Jun 30, 2024 | 84.98% |
| Mar 31, 2024 | -1,152.39% |
| Dec 31, 2023 | 25.89% |
| Sep 30, 2023 | -86.49% |
| Jun 30, 2023 | 48.60% |
| Mar 31, 2023 | 60.39% |
| Dec 31, 2022 | -356.95% |
| Sep 30, 2022 | 12.82% |
| Jun 30, 2022 | -189.86% |
| Mar 31, 2022 | 52.87% |
| Dec 31, 2021 | 45.86% |
| Sep 30, 2021 | -37.44% |
| Jun 30, 2021 | 79.70% |
| Mar 31, 2021 | 8.53% |
| Dec 31, 2020 | -220.14% |
| Sep 30, 2020 | -46.09% |
| Jun 30, 2020 | 55.25% |
| Mar 31, 2020 | -36.95% |
| Dec 31, 2019 | -138.50% |
| Sep 30, 2019 | 724.24% |
| Jun 30, 2019 | 23.79% |
| Mar 31, 2019 | 63.49% |
| Dec 31, 2018 | 51.65% |
| Sep 30, 2018 | 0.85% |
| Jun 30, 2018 | 20.37% |
| Mar 31, 2018 | -147.57% |
| Dec 31, 2017 | 9.97% |
| Sep 30, 2017 | 21.64% |
| Jun 30, 2017 | -83.59% |
| Mar 31, 2017 | 21.28% |
| Dec 31, 2016 | 29.01% |
| Sep 30, 2016 | -402.62% |
| Jun 30, 2016 | 106.17% |
| Mar 31, 2016 | -683.29% |
| Dec 31, 2015 | 244.07% |
| Sep 30, 2015 | -844.44% |
| Jun 30, 2015 | 88.84% |
| Mar 31, 2015 | 89.36% |
| Dec 31, 2014 | -1,027.72% |
| Sep 30, 2014 | -9.13% |
| Jun 30, 2014 | -26.18% |
| Mar 31, 2014 | -29.12% |
| Dec 31, 2013 | 56.90% |
| Sep 30, 2013 | 13.82% |
| Jun 30, 2013 | -1,697.93% |
| Mar 31, 2013 | 68.73% |
| Dec 31, 2012 | -43.93% |
| Sep 30, 2012 | 14.78% |
| Jun 30, 2012 | -309.68% |
| Mar 31, 2012 | -125.74% |
| Dec 31, 2011 | 166.24% |
| Sep 30, 2011 | -51.22% |
| Jun 30, 2011 | 57.63% |